Human Induced Pluripotent Stem Cell-Derived Pericytes as Scalable and Editable Source to Study Direct Lineage Reprogramming Into Induced Neurons

被引:0
作者
Menon, Radhika [1 ,8 ]
Petrucci, Linda [1 ]
Lohrer, Benjamin [1 ,9 ]
Zhang, Jingzhong [2 ,10 ]
Schulze, Markus [3 ]
Schichor, Christian [4 ]
Winner, Beate [5 ,6 ]
Winkler, Juergen [7 ]
Riemenschneider, Markus J. [3 ]
Kuehn, Ralf [2 ]
Falk, Sven [1 ]
Karow, Marisa [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany
[2] Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Genome Engn & Dis Models, Berlin, Germany
[3] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany
[4] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany
[5] Friedrich Alexander Univ Erlangen Nurnberg, Dept Stem Cell Biol, Erlangen, Germany
[6] Friedrich Alexander Univ Erlangen Nurnberg, Ctr Rare Dis Erlangen ZSEER, Erlangen, Germany
[7] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany
[8] Ncardia, Leiden, Netherlands
[9] Roche Diagnost GmbH, Mannheim, Germany
[10] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China
关键词
direct lineage reprogramming; pericytes; induced neurons; organoids; HUMAN BRAIN; GENERATION; PROTEIN;
D O I
10.1089/cell.2023.0008
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Studying human somatic cell-to-neuron conversion using primary brain-derived cells as starting cell source is hampered by limitations and variations in human biopsy material. Thus, delineating the molecular variables that allow changing the identity of somatic cells, permit adoption of neuronal phenotypes, and foster maturation of induced neurons (iNs) is challenging. Based on our previous results that pericytes derived from the adult human cerebral cortex can be directly converted into iNs (Karow et al., 2018; Karow et al., 2012), we here introduce human induced pluripotent stem cell (hiPSC)-derived pericytes (hiPSC-pericytes) as a versatile and more uniform tool to study the pericyte-to-neuron conversion process. This strategy enables us to derive scalable cell numbers and allows for engineering of the starting cell population such as introducing reporter tools before differentiation into hiPSC-pericytes and subsequent iN conversion. Harvesting the potential of this approach, we established hiPSC-derived human-human neuronal cocultures that not only allow for independent manipulation of each coculture partner but also resulted in morphologically more mature iNs. In summary, we exploit hiPSC-based methods to facilitate the analysis of human somatic cell-to-neuron conversion.
引用
收藏
页码:212 / 223
页数:12
相关论文
共 50 条
  • [41] Human Induced Pluripotent Stem Cell-Derived Models to Investigate Human Cytomegalovirus Infection in Neural Cells
    D'Aiuto, Leonardo
    Di Maio, Roberto
    Heath, Brianna
    Raimondi, Giorgio
    Milosevic, Jadranka
    Watson, Annie M.
    Bamne, Mikhil
    Parks, W. Tony
    Yang, Lei
    Lin, Bo
    Miki, Toshio
    Mich-Basso, Jocelyn Danielle
    Arav-Boger, Ravit
    Sibille, Etienne
    Sabunciyan, Sarven
    Yolken, Robert
    Nimgaonkar, Vishwajit
    PLOS ONE, 2012, 7 (11):
  • [42] Using human induced pluripotent stem cell-derived liver cells to investigate the mechanisms of liver fibrosis in vitro
    Koui, Yuta
    Kido, Taketomo
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2023, 51 (03) : 1271 - 1277
  • [43] Induction of Fenestrae in Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Disease Modeling
    Meijer, Elana M.
    van Dijk, Christian G. M.
    Giles, Rachel
    Gijsen, Karlijn
    Chrifi, Ihsan
    Verhaar, Marianne C.
    Cheng, Caroline
    TISSUE ENGINEERING PART A, 2024, 30 (3-4) : 168 - 180
  • [44] Implantation of Human-Induced Pluripotent Stem Cell-Derived Cartilage in Bone Defects of Mice
    Iimori, Yuki
    Morioka, Miho
    Koyamatsu, Saeko
    Tsumaki, Noriyuki
    TISSUE ENGINEERING PART A, 2021, 27 (21-22) : 1355 - 1367
  • [45] Membrane Properties of Human Induced Pluripotent Stem Cell-Derived Cultured Red Blood Cells
    Bernecker, Claudia
    Matzhold, Eva Maria
    Kolb, Dagmar
    Avdili, Afrim
    Rohrhofer, Lisa
    Lampl, Annika
    Troetzmueller, Martin
    Singer, Heike
    Oldenburg, Johannes
    Schlenke, Peter
    Dorn, Isabel
    CELLS, 2022, 11 (16)
  • [46] Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cells
    Kumar, Santhosh, V
    Er, Pei X.
    Lawlor, Kynan T.
    Motazedian, Ali
    Scurr, Michelle
    Ghobrial, Irene
    Combes, Alexander N.
    Zappia, Luke
    Oshlack, Alicia
    Stanley, Edouard G.
    Little, Melissa H.
    DEVELOPMENT, 2019, 146 (05):
  • [47] Clinical Application of Human Induced Pluripotent Stem Cell-Derived Organoids as an Alternative to Organ Transplantation
    Ping Hsia, Gabriella Shih
    Esposito, Joyce
    da Rocha, Leticia Alves
    Guimaraes Ramos, Sofia Ligia
    Okamoto, Oswaldo Keith
    STEM CELLS INTERNATIONAL, 2021, 2021
  • [48] Differentiation and Transplantation of Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells
    Asgari, Samira
    Moslem, Mohsen
    Bagheri-Lankarani, Kamran
    Pournasr, Behshad
    Miryounesi, Maryam
    Baharvand, Hossein
    STEM CELL REVIEWS AND REPORTS, 2013, 9 (04) : 493 - 504
  • [49] Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
    Dupuis, Victoria
    Oltra, Elisa
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (08): : 1094 - 1111
  • [50] Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies
    Selvaraj, Vimal
    Plane, Jennifer M.
    Williams, Ambrose J.
    Deng, Wenbin
    TRENDS IN BIOTECHNOLOGY, 2010, 28 (04) : 214 - 223